|
More
Blister/Sealing/Skin Equipment
Research Library
|
|
McLeod & Dewey Associates
|
The following is an unbiased view of what to look for in both a stretch film, and a stretch film supplier. Using information provided by our customers we have come to realize that some of them get much more value than others from their stretch film supplier. And that extra value has resulted in thousands of dollars saved. We have outlined some of these points below in an attempt to let our ...
|
|
|
Service Industries LLC
|
In particular Dr Dixon found that the laser based Blisterscan, manufactured in the UK by Sepha, was capable of detecting 15% more product defects than traditional blue dye test methods used by the majority of the pharmaceutical market. In a global market valued at over $40 billion per annum, where quality control is of paramount importance, a 15% difference in the ability to detect if a product ...
|
|
|
Service Industries LLC
|
Demonstrating the integrity of pharmaceutical blister packs is critically important, as any defects can affect the shelf life and efficacy of the contents. Compared to bulk packaging, blister packs offer improved product integrity, tamper evidence and reduce the likelihood of misuse. This paper discusses how the VisionScan can be used to identify leaks more easily than traditional blue dye ...
|
|
|
Menges Roller Company
|
The Basic Theory of Crowning Industrial Rollers
Written by Matthew Menges & Javier Carreon
260 Industrial Dr., Wauconda, Il 60084-1077 ▼ (847) 487-8877 Fax (847) 487-8897
The Basic Theory of Crowning Industrial Rollers
Rollers that are crowned are utilized by many industrial manufacturers. These companies are in the paper, film and foil converting industry. As a roller manufacturer, ...
|
|
|
New England Machinery, Inc.
|
By Marge Bonura, New England Machinery, Inc., 2012
The counterfeit drug industry has an estimated value of $205 billion and is swiftly growing. This out-of –control scourge is responsible for 2,000 deaths per day worldwide.1 The FDA and pharmaceutical companies have struggled to find a solution that is efficient and cost effective. After a 2008 situation in which the blood thinner Heparin was ...
|
|
|
|
